EMD-26263

Single-particle
3.86 Å
EMD-26263
3D View Gallery
Deposition: 18/02/2022
Map released: 01/03/2023
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-26263

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7u0q summary report (pdf.gz) Map-7u0q FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02

EMD-26263

Single-particle
3.86 Å
EMD-26263
3D View Gallery
Deposition: 18/02/2022
Map released: 01/03/2023
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: Cov2 Spike timer in complex with monoclonal antibody
Fitted models: 7u0q

Deposition Authors: Patel A, Ortlund E
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.
Patel A, Kumar S , Lai L, Chakravarthy C, Valanparambil R, Reddy ES, Gottimukkala K, Bajpai P, Raju DR, Edara VV, Davis-Gardner ME , Linderman S, Dixit K, Sharma P, Mantus G, Cheedarla N , Verkerke HP, Frank F, Neish AS, Roback JD, Davis CW, Wrammert J, Ahmed R, Suthar MS, Sharma A, Murali-Krishna K, Chandele A, Ortlund EA
(2023) Structure , 31 , 801 - 811.e5
PUBMED: 37167972
DOI: doi:10.1016/j.str.2023.04.010
ISSN: 0969-2126
ASTM: STRUE6